Cybersecurity veterans to accelerate Remedioโs global category leadership in autonomous exposure remediation
WILMINGTON, DE, UNITED STATES, May 6, 2026 /EINPresswire.com/ — Remedio, the pioneer in autonomous security remediation and AI posture management, today announced the appointments of ๐๐๐ป๐๐ต๐ถ๐ฎ ๐ฆ๐๐ฎ๐ป๐๐ผ๐ป as Chief Marketing Officer and ๐ ๐ผ๐ฟ ๐๐ถ๐ธ๐ผ๐๐๐ธ๐ as Chief Business Officer. Unlike traditional tools that merely monitor risk, Remedio is the only platform that safely and automatically fixes misconfigurations and vulnerabilities across endpoints, servers, networking devices, and enterprise AI agents. Coming on the heels of a $65M Series A and rapid global adoption by Fortune 500 companies, Stanton and Bikovsky bring decades of experience to drive Remedioโs next phase of hyper growth across global enterprise markets.
โMor and Cindy each bring something unique to Remedio,โ said CEO Tal Kollender. โMor combines deep technical credibility with the commercial execution to build and scale global partnerships. Cindy has lived the remediation gap firsthand, from both the product and the marketing chair. Together they will help us define and lead this category.โ
Cindy Stanton joins Remedio with 20+ years of cybersecurity GTM leadership and a track record scaling companies from early growth to $800M+ in revenue. Most recently, as CMO at Rapid7, she led a 110-person global marketing organization and transformed the function to full-funnel ARR accountability, contributing to revenue growth to ~$840M. Prior to becoming CMO, she ran the Vulnerability Risk Management business unit working firsthand with thousands of customers struggling to drive risk reduction at scale, the precise problem Remedio solves.
At Remedio, she will lead product marketing, demand generation, brand and communications, and customer lifecycle marketing.
โI spent years watching security teams discover risks they couldnโt fix at scale,โ said CMO Cindy Stanton. โThat gap between knowing and doing is the most urgent unsolved problem in enterprise security and Remedio has closed it. Iโm excited to be a part of Remedio and help the market understand that.โ
Mor Bikovsky brings 15+ years of cybersecurity experience, two of which have been with Remedio, with a focus on global go-to-market strategy and customer engagement. She spent six years at Claroty building and scaling global strategic partnerships across critical infrastructure and industrial sectors, playing a key role in defining the Cyber-Physical Systems (CPS) security category. Before that, she served seven years in the Israel Defense Forces Intelligence Corps in elite technology units, developing an execution-focused leadership style forged in high-stakes environments.
โThese past two years have been a whirlwind as we made major strides in growing Remedioโs business,โ said CBO Mor Bikovsky. โItโs an honor to continue growing with this team, leading Remedio into the future as the leader in autonomous exposure remediation.โ
โโโโโโโโโโโโโโโโโโโโโโโ
๐๐ฏ๐ผ๐๐ ๐ฅ๐ฒ๐บ๐ฒ๐ฑ๐ถ๐ผ
Remedio is the leading preemptive cybersecurity platform built to eliminate the gap between detecting risk and actually fixing it. From legacy infrastructure to modern AI agents, Remedio autonomously resolves misconfigurations, patches vulnerabilities, and enforces continuous compliance with guaranteed zero-disruption and instant rollback. Securing over 3 million devices for more than 300 global enterprises, including Amazon, Colgate-Palmolive, and Ulta Beauty, Remedio transforms security posture from a manual burden into an automated advantage.
Bootstrapped to profitability by CEO and founder Tal Kollender in 2019, Remedio is now fueled by a $65M Series A led by Bessemer Venture Partners, alongside TLV Partners and Picture Capital. Learn more at www.remedio.io.
๐ ๐ฒ๐ฑ๐ถ๐ฎ ๐๐ผ๐ป๐๐ฎ๐ฐ๐
Kari Porter
remedio@scoutlab.com
Scout Lab
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Media gallery
